Society of Regenerative Sciences (India)

(Formerly known as Stem Cell Society (India))

Event Registration Membership Form

International Publications On Ophthalmological Conditions

Ophthalmological Conditions Publications

  1. Li L, Yu Y, Lin S, Hu J. Changes in best-corrected visual acuity in patients with dry age-related macular degeneration after stem cell transplantation: systematic review and meta-analysis. Stem Cell Res Ther. 2022 Jun 7;13(1):237. doi: 10.1186/s13287-022-02931-y. PmiD: 35672801; PMCID: PMC9172101.
  2. Calonge M, Pérez I, Galindo S, Nieto-miguel T, López-Paniagua M, Fernández I, Alberca M, García-Sancho J, Sánchez A, Herreras JM. A proof-of-concept clinical trial using mesenchymal stem cells for the treatment of corneal epithelial stem cell deficiency. Transl Res. 2019 Apr;206:18-40. doi: 10.1016/j.trsl.2018.11.003. Epub 2018 Nov 22. PmiD: 30578758.
  3. Møller-Hansen M, Larsen AC, Toft PB, Lynggaard CD, Schwartz C, Bruunsgaard H, Haack-Sørensen M, Ekblond A, Kastrup J, Heegaard S. Safety and feasibility of mesenchymal stem cell therapy in patients with aqueous deficient dry eye disease. Ocul Surf. 2021 Jan;19:43-52. doi: 10.1016/j.jtos.2020.11.013. Epub 2020 Nov 28. PmiD: 33253910.
  4. Figueiredo FC, Glanville JM, Arber M, Carr E, Rydevik G, Hogg J, Okonkwo A, Figueiredo G, Lako M, Whiter F, Wilson K. A systematic review of cellular therapies for the treatment of limbal stem cell deficiency affecting one or both eyes. Ocul Surf. 2021 Apr;20:48-61. doi: 10.1016/j.jtos.2020.12.008. Epub 2021 Jan 4. PmiD: 33412337.
  5. Weiss JN, Levy S. Stem cell ophthalmology treatment study (SCOTS): bone marrow-derived stem cells in the treatment of Stargardt disease. Medicines. 2021 Feb 3;8(2):10.
  6. Weiss JN, Levy S. Stem cell ophthalmology treatment study (SCOTS): bone marrow-derived stem cells in the treatment of age-related macular degeneration. Medicines. 2020 Mar 28;7(4):16.
  7. Weiss JN, Levy S. Stem Cell Ophthalmology Treatment Study (SCOTS): bone marrow derived stem cells in the treatment of Dominant Optic Atrophy. Stem Cell Investig 2019;6:41.
  8. Tuekprakhon A, Sangkitporn S, Trinavarat A, Pawestri AR, Vamvanij V, Ruangchainikom M, Luksanapruksa P, Pongpaksupasin P, Khorchai A, Dambua A, Boonchu P, Yodtup C, Uiprasertkul M, Sangkitporn S, Atchaneeyasakul LO. Intravitreal autologous mesenchymal stem cell transplantation: a non-randomized phase I clinical trial in patients with retinitis pigmentosa. Stem Cell Res Ther. 2021 Jan 9;12(1):52. doi: 10.1186/s13287-020-02122-7. PmiD: 33422139; PMCID: PMC7796606.
  9. Rama P, Matuska S, Paganoni G, Spinelli A, De Luca M, Pellegrini G. Limbal stem-cell therapy and long-term corneal regeneration. N Engl J Med. 2010 Jul 8;363(2):147-55.
  10. Schwartz SD, Regillo CD, Lam BL, Eliott D, Rosenfeld PJ, Gregori NZ, Hubschman JP, Davis JL, Heilwell G, Spirn M, Maguire J, Gay R, Bateman J, Ostrick RM, Morris D, Vincent M, Anglade E, Del Priore LV, Lanza R. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies. Lancet. 2015 Feb 7;385(9967):509-16.
  11. Song WK, Park KM, Kim HJ, Lee JH, Choi J, Chong SY, Shim SH, Del Priore LV, Lanza R. Treatment of macular degeneration using embryonic stem cell-derived retinal pigment epithelium: preliminary results in Asian patients. Stem Cell Reports. 2015 May 12;4(5):860-72.
  12. da Cruz L, Fynes K, Georgiadis O, Kerby J, Luo YH, Ahmado A, Vernon A, Daniels JT, Nommiste B, Hasan SM, Gooljar SB, Carr AF, Vugler A, Ramsden CM, Bictash M, Fenster M, Steer J, Harbinson T, Wilbrey A, Tufail A, Feng G, Whitlock M, Robson AG, Holder GE, Sagoo MS, Loudon PT, Whiting P, Coffey PJ. Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration. Nat Biotechnol. 2018 Apr;36(4):328-337.
  13. Mandai M, Watanabe A, Kurimoto Y, Hirami Y, Morinaga C, Daimon T, Fujihara M, Akimaru H, Sakai N, Shibata Y, Terada M, Nomiya Y, Tanishima S, Nakamura M, Kamao H, Sugita S, Onishi A, Ito T, Fujita K, Kawamata S, Go MJ, Shinohara C, Hata KI, Sawada M, Yamamoto M, Ohta S, Ohara Y, Yoshida K, Kuwahara J, Kitano Y, Amano N, Umekage M, Kitaoka F, Tanaka A, Okada C, Takasu N, Ogawa S, Yamanaka S, Takahashi M. Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration. N Engl J Med. 2017 Mar 16;376(11):1038-1046.
  14. Park SS, Bauer G, Abedi M, Pontow S, Panorgias A, Jonnal R, Zawadzki RJ, Werner JS, Nolta J. Intravitreal autologous bone marrow CD34+ cell therapy for ischemic and degenerative retinal disorders: preliminary phase 1 clinical trial findings. Invest Ophthalmol Vis Sci. 2015 Jan 6;56(1):81-9. doi: 10.1167/iovs.14-15415. PubMed PmiD: 25491299; PubMed Central PMCID: PMC4288143.
  15. Tsubota K, Satake Y, Kaido M, Shinozaki N, Shimmura S, Bissen-miyajima H, Shimazaki J. Treatment of severe ocular-surface disorders with corneal epithelial stem-cell transplantation. N Engl J Med. 1999 Jun 3;340(22):1697-703.
  16. Özmert E, Arslan U. Management of retinitis pigmentosa by Wharton's jelly-derived mesenchymal stem cells: prospective analysis of 1-year results. Stem Cell Res Ther. 2020 Aug 12;11(1):353. doi: 10.1186/s13287-020-01870-w. PmiD: 32787913; PMCID: PMC7425139.
  17. El Zarif M, Alió JL, Alió Del Barrio JL, Abdul Jawad K, Palazón-Bru A, Abdul Jawad Z, De miguel MP, Makdissy N. Corneal Stromal Regeneration Therapy for Advanced Keratoconus: Long-term Outcomes at 3 Years. Cornea. 2021 Jun 1;40(6):741-754. doi: 10.1097/ICO.0000000000002646. PmiD: 33591032.
  18. Kahraman NS, Oner A. Umbilical cord derived mesenchymal stem cell implantation in retinitis pigmentosa: a 6-month follow-up results of a phase 3 trial. International Journal of Ophthalmology. 2020;13(9):1423.
  19. Kahraman NS, Öner A. Umbilical cord-derived mesenchymal stem cell implantation in patients with optic atrophy. European Journal of Ophthalmology. 2021 Nov;31(6):3463-70.
  20. Abukhalil F, Lam BL, Guy J. Visual Observations of an American Patient With Leber Hereditary Optic Neuropathy After Purported Injections of Stem Cells in China. Arch Ophthalmol. 2012;130(4):532–534. doi:10.1001/archophthalmol.2011.1665
  21. Niu Y, Ji J, Yao K, Fu Q. Regenerative treatment of ophthalmic diseases with stem cells: Principles, progress, and challenges. Advances in Ophthalmology Practice and Research. 2024;4(2):52-64.
  22. Akbaribazm M. Exploring the regenerative potential of stem cells for treating eye diseases: A review of the new findings. OBM Genetics. 2024;8(1):1-14.
  23. Soleimani M, Masoumi A, Momenaei B, Cheraqpour K, Koganti R, Chang AY, Djalilian AR. Applications of mesenchymal stem cells in ocular surface diseases: sources and routes of delivery. Expert Opin Biol Ther. 2023;23(6):509–525.
  24. Balkan BC, Erbaş O. Recent advances in stem cell-based therapeutics in ophthalmology. Demiroglu Sci Univ Florence Nightingale J Med. 2023;9(3):175-182.
  25. Liu F, Li Q, Yang Y, Lu F. Advances in Stem Cell Therapies for Ocular Diseases: Progress in Clinical Trials and Future Perspectives. Stem Cell Rev Rep. 2025:1-21.
  26. Chen X, Xu N, Li J, Zhao M, Huang L. Stem cell therapy for inherited retinal diseases: a systematic review and meta-analysis. Stem Cell Res Ther. 2023;14(1):286.
  27. Posarelli M, Romano D, Tucci D, Giannaccare G, Scorcia V, Taloni A, Borgia A. Ocular-surface regeneration therapies for eye disorders: The state of the art. BioTech. 2023;12(2):48.
  28. Surico PL, Barone V, Singh RB, Coassin M, Blanco T, Dohlman TH, Di Zazzo A. Potential applications of mesenchymal stem cells in ocular surface immune-mediated disorders. Surv Ophthalmol. 2025;70(3):467-479.
  29. Massoumi H, Amin S, Soleimani M, Momenaei B, Ashraf MJ, Guaiquil VH, Jalilian E. Extracellular-vesicle-based therapeutics in neuro-ophthalmic disorders. Int J Mol Sci. 2023;24(10):9006.
  30. Voisin A, Pénaguin A, Gaillard A, Leveziel N. Stem cell therapy in retinal diseases. Neural Regen Res. 2023;18(7):1478-1485.
  31. Finocchio L, Zeppieri M, Gabai A, Spadea L, Salati C. Recent advances of adipose-tissue-derived mesenchymal stem cell-based therapy for retinal diseases. J Clin Med. 2023;12(22):7015.